DK0567576T3 - Behandling af neoplastiske sygdomme med interleukin-10 - Google Patents

Behandling af neoplastiske sygdomme med interleukin-10

Info

Publication number: DK0567576T3
Authority: DK; Denmark
Prior art keywords: interleukin; treatment; neoplastic diseases; neoplastic; diseases
Prior art date: 1991-01-16

Application number

DK92904687.8T

Other languages

English (en)

Inventor

Kevin W Moore

Paulo J M Vieira

Original Assignee

Schering Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-01-16

Filing date

1992-01-15

Publication date

1995-06-12

1992-01-15 Application filed by Schering Corp filed Critical Schering Corp

1995-06-12 Application granted granted Critical

1995-06-12 Publication of DK0567576T3 publication Critical patent/DK0567576T3/da

Links

102000003814 Interleukin-10 Human genes 0.000 title abstract 2
108090000174 Interleukin-10 Proteins 0.000 title abstract 2
229940076144 interleukin-10 Drugs 0.000 title abstract 2
201000010099 disease Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
230000001613 neoplastic effect Effects 0.000 title 1
206010028980 Neoplasm Diseases 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5428—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2066—IL-10
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
- C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Zoology (AREA)
Virology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Ultra Sonic Daignosis Equipment (AREA)

DK92904687.8T 1991-01-16 1992-01-15 Behandling af neoplastiske sygdomme med interleukin-10 DK0567576T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US64134791A	1991-01-16	1991-01-16

Publications (1)

Publication Number	Publication Date
DK0567576T3 true DK0567576T3 (da)	1995-06-12

Family

ID=24571976

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92904687.8T DK0567576T3 (da)	1991-01-16	1992-01-15	Behandling af neoplastiske sygdomme med interleukin-10

Country Status (18)

Country	Link
EP (1)	EP0567576B1 (da)
JP (1)	JP3260368B2 (da)
KR (1)	KR100207766B1 (da)
AT (1)	ATE116550T1 (da)
AU (1)	AU652030B2 (da)
CA (1)	CA2100553A1 (da)
CZ (1)	CZ282523B6 (da)
DE (1)	DE69201128T2 (da)
DK (1)	DK0567576T3 (da)
ES (1)	ES2068705T3 (da)
FI (1)	FI933193A0 (da)
GR (1)	GR3015510T3 (da)
HK (1)	HK192196A (da)
HU (1)	HU218598B (da)
NO (1)	NO310444B1 (da)
OA (1)	OA09908A (da)
SK (1)	SK279556B6 (da)
WO (1)	WO1992012725A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6106823A (en) *	1991-01-16	2000-08-22	Schering Corporation	Treatment of neoplastic disease with interleukin-10
DE4122402A1 (de) *	1991-07-04	1993-01-07	Schering Ag	Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit
MY111402A (en) *	1992-08-20	2000-04-29	Schering Corp	Novel uses of il-4 and/or il-10, and antibodies against the same
US5601815A (en) *	1992-08-21	1997-02-11	Schering Corp	IL-4 and IL-10 to downregulate delayed-type hypersensitivity and cytokine expresion by T-cells
TW381026B (en) *	1993-01-13	2000-02-01	Schering Corp	Method of extracorporally activating cytolytic activity of peripheral blood mononuclear cells and pharmaceutical composition comprising the activated peripheral blood mononuclear cells
CN1142186A (zh) *	1994-01-20	1997-02-05	先灵公司	用白介素-10激活外周血单核细胞的细胞溶解活性
CA2205572A1 (en)	1994-12-12	1996-06-20	Beth Israel Hospital Association	Chimeric cytokines and uses thereof
US6410008B1 (en)	1994-12-12	2002-06-25	Beth Israel Hospital Association	Chimeric IL-10 proteins and uses thereof
US5770190A (en) *	1995-07-14	1998-06-23	Schering Corporation	Method of treatment of acute leukemia with inteleukin-10
WO2001005821A2 (en) *	1999-07-16	2001-01-25	Maria Teresa Bejarano	Viral il-10 for the inhibition of angiogenesis, tumorigenesis and metastasis
EP1324779B1 (en)	2000-09-29	2011-07-20	Schering Corporation	Pegylated interleukin-10
MX2009003362A (es)	2006-09-28	2009-06-08	Schering Corp	Uso de interleucina-10 pegilada para tratamiento de cancer.
ES2655364T3 (es)	2008-12-17	2018-02-19	Merck Sharp & Dohme Corp.	Producción de IL-10 mono- y dipegilada y sus usos
BR112015026122A8 (pt)	2013-04-18	2020-01-21	Armo Biosciences Inc	agente de polietileno glicol-il-10 (peg-il-10), seu uso, composição farmacêutica, contentor estéril e kit
ES2688206T3 (es)	2013-06-17	2018-10-31	Armo Biosciences, Inc.	Procedimiento de evaluación de la identidad y la estabilidad de proteínas
US10010588B2 (en)	2013-08-30	2018-07-03	Armo Biosciences, Inc.	Methods of using pegylated interleukin-10 for treating hyperlipidemia
JP6660297B2 (ja)	2013-11-11	2020-03-11	アルモ・バイオサイエンシーズ・インコーポレイテッド	疾患及び障害を処置するためのインターロイキン−１０の使用方法
US10293043B2 (en)	2014-06-02	2019-05-21	Armo Biosciences, Inc.	Methods of lowering serum cholesterol
MX2017004838A (es)	2014-10-14	2017-10-16	Armo Biosciences Inc	Composiciones de interleucina-15 y usos de estas.
JP6675394B2 (ja)	2014-10-22	2020-04-01	アルモ・バイオサイエンシーズ・インコーポレイテッド	疾患及び障害の治療のためにインターロイキン−１０を使用する方法
WO2016126615A1 (en)	2015-02-03	2016-08-11	Armo Biosciences, Inc.	Methods of using interleukin-10 for treating diseases and disorders
WO2016191587A1 (en)	2015-05-28	2016-12-01	Armo Biosciences, Inc.	Pegylated interleukin-10 for use in treating cancer
EP3341012A4 (en)	2015-08-25	2019-03-20	Armo Biosciences, Inc.	METHOD FOR USE OF INTERLEUKIN-10 FOR THE TREATMENT OF ILLNESSES AND SUFFERING

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IL94878A (en) *	1989-06-28	2003-01-12	Schering Corp	Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same
WO1991009127A1 (en) *	1989-12-20	1991-06-27	Schering Corporation	BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g)

1992
- 1992-01-15 DE DE69201128T patent/DE69201128T2/de not_active Expired - Fee Related
- 1992-01-15 HU HU9302066A patent/HU218598B/hu not_active IP Right Cessation
- 1992-01-15 SK SK747-93A patent/SK279556B6/sk unknown
- 1992-01-15 CZ CS931412A patent/CZ282523B6/cs not_active IP Right Cessation
- 1992-01-15 DK DK92904687.8T patent/DK0567576T3/da active
- 1992-01-15 AU AU12617/92A patent/AU652030B2/en not_active Ceased
- 1992-01-15 JP JP50528792A patent/JP3260368B2/ja not_active Expired - Fee Related
- 1992-01-15 AT AT92904687T patent/ATE116550T1/de not_active IP Right Cessation
- 1992-01-15 WO PCT/US1992/000066 patent/WO1992012725A1/en active IP Right Grant
- 1992-01-15 EP EP92904687A patent/EP0567576B1/en not_active Expired - Lifetime
- 1992-01-15 ES ES92904687T patent/ES2068705T3/es not_active Expired - Lifetime
- 1992-01-15 CA CA002100553A patent/CA2100553A1/en not_active Abandoned
- 1992-01-15 KR KR1019930702114A patent/KR100207766B1/ko not_active Expired - Fee Related
1993
- 1993-07-07 OA OA60389A patent/OA09908A/xx unknown
- 1993-07-14 FI FI933193A patent/FI933193A0/fi unknown
- 1993-07-15 NO NO19932570A patent/NO310444B1/no not_active IP Right Cessation
1995
- 1995-03-21 GR GR950400642T patent/GR3015510T3/el unknown
1996
- 1996-10-17 HK HK192196A patent/HK192196A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
NO932570L (no)	1993-07-15
HUT69962A (en)	1995-09-28
CA2100553A1 (en)	1992-07-17
FI933193L (fi)	1993-07-14
ATE116550T1 (de)	1995-01-15
SK74793A3 (en)	1995-03-08
NO932570D0 (no)	1993-07-15
DE69201128T2 (de)	1995-05-24
AU1261792A (en)	1992-08-27
CZ282523B6 (cs)	1997-07-16
KR100207766B1 (ko)	1999-07-15
AU652030B2 (en)	1994-08-11
JP3260368B2 (ja)	2002-02-25
ES2068705T3 (es)	1995-04-16
WO1992012725A1 (en)	1992-08-06
EP0567576B1 (en)	1995-01-04
FI933193A0 (fi)	1993-07-14
DE69201128D1 (de)	1995-02-16
SK279556B6 (sk)	1998-12-02
GR3015510T3 (en)	1995-06-30
HU218598B (hu)	2000-10-28
HK192196A (en)	1996-10-25
EP0567576A1 (en)	1993-11-03
CZ141293A3 (en)	1994-01-19
NO310444B1 (no)	2001-07-09
HU9302066D0 (en)	1993-11-29
OA09908A (en)	1994-09-15
JPH06504785A (ja)	1994-06-02

Publication	Publication Date	Title
DK0567576T3 (da)	1995-06-12	Behandling af neoplastiske sygdomme med interleukin-10
ATE69376T1 (de)	1991-11-15	Haarwuchsmittel.
KR890701107A (ko)	1989-12-19	알쯔하이머 병 치료용 화합물들
ES2074565T3 (es)	1995-09-16	Empleo de melatonina para tratar el sindrome pre-menstrual.
DK0637238T3 (da)	1999-08-30	Behandling af makuløs degenerering
KR930702026A (ko)	1993-09-08	자기항원의 경구 투여에 의한 자기면역 질병의 치료
BG96892A (bg)	1993-12-24	Метод и устройство за разпределяне на медикаменти съответствуващи на предписаното лечение на даден пациент
DE69300321D1 (de)	1995-09-07	Behandlung neurodegenerativer Erkrankungen.
HU891056D0 (en)	1991-06-28	Process for treating the diseases of the gullet and the stomach-intestine system
DK472688D0 (da)	1988-08-24	Anvendelse af bezafibrat til behandling af diabetes
MY104521A (en)	1994-04-30	Treatment of depression.
DK0617959T3 (da)	2000-01-24	Lægemiddel til behandling af hudsygdomme
DK0588873T3 (da)	1997-09-15	Behandling af levercancer
ES2117008T3 (es)	1998-08-01	Metodo de tratamiento con amperozida de la esquizofrenia resistente a la terapia.
DE69307702D1 (de)	1997-03-06	Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
SE8306384L (sv)	1984-05-21	Farmaceutisk komposition
SE9000658L (sv)	1990-09-15	Medel foer behandling av soemnapne
DE3786442D1 (de)	1993-08-12	Verwendung von follikelreifungshormon zur herstellung eines therapeutischen mittels zur behandlung von neoplasmen von gonadalem ursprung.
PT1304107E (pt)	2005-09-30	Utilizacao de derivados de oxazolidininas para o tratamento da psoriase
PL283664A1 (en)	1991-08-12	Therapeutical set for treating limb bone fractures by traction
NO934444D0 (no)	1993-12-07	Lyskilde for PDT-behandling av hudlidelser
IT1228977B (it)	1991-07-11	Apparecchio fisioterapico per la cura della sterilita' femminile accertata e per la dilatazione indolore del canale cervicale.
BR8904799A (pt)	1990-04-03	Aparelho de fototerapia para o tratamento de ictericia do recem nascido
IT9086214A0 (it)	1990-03-19	Cura o guarigione del cancro o maurosalute
SE9003140D0 (sv)	1990-10-02	Method and composition for treatment of heart diseases